Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
241,754
-
Share change
-
-12,164
-
Total reported value
-
$469,203
-
Price per share
-
$1.94
-
Number of holders
-
8
-
Value change
-
-$47,223
-
Number of buys
-
3
-
Number of sells
-
4
Institutional Holders of Innate Pharma SA - SPONSORED ADS (IPHA) as of Q2 2024
As of 30 Jun 2024,
Innate Pharma SA - SPONSORED ADS (IPHA) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
241,754 shares.
The largest 8 holders included
Optiver Holding B.V., EXCHANGE TRADED CONCEPTS, LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, BARCLAYS PLC, UBS Group AG, RHUMBLINE ADVISERS, and Steward Partners Investment Advisory, LLC.
This page lists
8
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.